Finance

Lists
MXCT:NASDAQ
MaxCyte Inc
$1.38
0.00%
(0.00) 1D
Aug 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MXCT...
Open
$1.40
High
$1.40
Low
$1.36
Mkt. cap
142.42M
Avg. vol.
982.40K
Volume
435.91K
52-wk high
$1.86
52-wk low
$0.64
EPS
-$0.33
Beta
1.48
Shares outstanding
103.21M
No. of employees
91
Open
$1.40
High
$1.40
Low
$1.36
Mkt. cap
142.42M
Avg. vol.
982.40K
Volume
435.91K
52-wk high
$1.86
52-wk low
$0.64
EPS
-$0.33
Beta
1.48
Shares outstanding
103.21M
No. of employees
91
News stories
From web sources and news partners
About MaxCyte Inc
CEO-
Employees91
Founded1998
HeadquartersRockville, Maryland, United States
SectorHealth care
Websitemaxcyte.com
Analyst ratings
Based on 3 analysts giving stock ratings to MXCT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MXCT in the last 3 months.
Highest
Current $1.38
$4.00 (+189.86%)
Average
$4.00 (+189.86%)
Lowest
$4.00 (+189.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$4.00
+189.9%
08/13/2026
Brendan Smith
TD Cowen
Buy
Maintained
-
-
08/13/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
07/02/2026
Matt Larew
William Blair
Hold
Maintained
-
-
05/13/2026
Mark Massaro
BTIG
Hold
Reiterated
-
-
05/13/2026
Last report
Aug 12, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.08 / -$0.09
+14.28%beat
Revenue / Est. (USD)
7.27M / 6.47M
+12.43%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.83M
7.30M
9.65M
7.27M
Cost of goods sold
1.60M
1.61M
1.57M
1.68M
Cost of revenue
1.60M
1.61M
1.57M
1.68M
Research and development expenses
5.32M
3.34M
3.86M
4.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.96M
8.24M
9.39M
10.62M
Operating expense
16.32M
12.61M
14.27M
15.83M
Total operating expenses
17.92M
14.22M
15.84M
17.50M
Operating income
-11.09M
-6.92M
-6.18M
-10.23M
Other non operating income
-
-
-
-
EBT including unusual items
-12.42M
-9.60M
-4.75M
-8.87M
EBT excluding unusual items
-9.36M
-5.29M
-4.75M
-8.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.42M
-9.60M
-4.75M
-8.87M
Net profit margin
-181.81%
-131.45%
-49.22%
-122.05%
Earnings per share
-0.09
-0.06
-0.04
-0.08
Interest and investment income
1.73M
1.63M
1.44M
1.36M
Interest expense
-
-
-
-
Net interest expenses
1.73M
1.63M
1.44M
1.36M
Depreciation and amortization charges
1.04M
1.04M
1.02M
953.00K
EBITDA
-10.03M
-5.86M
-5.14M
-9.25M
Gain or loss from assets sale
34.00K
168.00K
14.00K
110.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps